107 filings
Page 5 of 6
8-K
ygc223v
22 Mar 17
Regulation FD Disclosure
12:00am
8-K
66p k9j0uw
16 Mar 17
Proteon Therapeutics Announces Full-Year 2016 Financial Results and Changes to the Ongoing Phase 3 PATENCY-2 Clinical Trial
12:00am
8-K
qdkv1i 0r9xo8na3ia7h
13 Dec 16
Proteon Therapeutics Announces Top-Line Data from Phase 3 PATENCY-1 Clinical Trial of Investigational Vonapanitase in Patients with CKD
12:00am
8-K
ku7t0bzanwr1ds3q8970
7 Nov 16
Proteon Therapeutics Announces Third Quarter 2016 Financial Results
12:00am
8-K
ukx422wx qpe
20 Oct 16
Proteon Therapeutics Appoints Paul Hastings Chairman of Its Board of Directors
12:00am
8-K
caat5 6e4ziqa4fp
8 Aug 16
Proteon Therapeutics Announces Second Quarter 2016 Financial Results
12:00am
8-K
cc4yuge a5f
13 Jun 16
Submission of Matters to a Vote of Security Holders
12:00am
8-K
de08c1
9 May 16
Proteon Therapeutics Announces First Quarter 2016 Financial Results
12:00am
8-K
ef56usmv2ue5yqrj5
14 Mar 16
Proteon Therapeutics Announces Fourth Quarter and Full-Year 2015 Financial Results
12:00am
8-K
e6n0vyr sz5e
22 Jan 16
Entry into a Material Definitive Agreement
12:00am
8-K
ijhv6
12 Nov 15
Entry into a Material Definitive Agreement
12:00am
8-K
cg3m5o
12 Nov 15
Results of Operations and Financial Condition
12:00am
8-K
c8et132
2 Nov 15
Regulation FD Disclosure
12:00am
8-K
yx4l3tso vyuw
19 Oct 15
Departure of Directors or Certain Officers
12:00am
8-K
fluy8mo
13 Aug 15
Results of Operations and Financial Condition
12:00am
8-K
06n1q upqv727n54fe
13 Aug 15
Regulation FD Disclosure
12:00am
8-K
o9rzucruzr2v73ry
22 Jul 15
Departure of Directors or Certain Officers
12:00am
8-K
d3x3yz9 mcg3v42b3
13 Jul 15
Entry into a Material Definitive Agreement
12:00am
8-K
7d25zk2xbw1 scb
5 Jun 15
Submission of Matters to a Vote of Security Holders
12:00am
8-K
q3ymqmf3b3vda so1hr
2 Jun 15
Departure of Directors or Certain Officers
12:00am